FDA approves first-of-its-kind pain medication for long-lasting relief

The FDA has granted approval for Kenvue's Tylenol with Naproxen, marking the first time a single pill combines acetaminophen and naproxen sodium. These two pain relievers, which consumers frequently use in combination, are now available as a unified 12-hour dose. This first-of-its-kind medication is designed to provide long-lasting relief for patients. The approval streamlines the administration of these active ingredients into one convenient pharmaceutical product for improved pain management and extended duration of efficacy.